186 related articles for article (PubMed ID: 21861138)
1. Head and neck manifestations of 22q11.2 deletion syndromes.
Marom T; Roth Y; Goldfarb A; Cinamon U
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):381-7. PubMed ID: 21861138
[TBL] [Abstract][Full Text] [Related]
2. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
[TBL] [Abstract][Full Text] [Related]
3. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
4. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.
Toth G; Zraly CB; Thomson TL; Jones C; Lapetino S; Muraskas J; Zhang J; Dingwall AK
Genes Chromosomes Cancer; 2011 Jun; 50(6):379-88. PubMed ID: 21412926
[TBL] [Abstract][Full Text] [Related]
5. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
[TBL] [Abstract][Full Text] [Related]
6. Growth characteristics and endocrine abnormalities in 22q11.2 deletion syndrome.
Levy-Shraga Y; Gothelf D; Goichberg Z; Katz U; Somech R; Pinhas-Hamiel O; Modan-Moses D
Am J Med Genet A; 2017 May; 173(5):1301-1308. PubMed ID: 28421700
[TBL] [Abstract][Full Text] [Related]
7. Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.
Monteiro FP; Vieira TP; Sgardioli IC; Molck MC; Damiano AP; Souza J; Monlleó IL; Fontes MI; Fett-Conte AC; Félix TM; Leal GF; Ribeiro EM; Banzato CE; Dantas Cde R; Lopes-Cendes I; Gil-da-Silva-Lopes VL
Eur J Pediatr; 2013 Jul; 172(7):927-45. PubMed ID: 23440478
[TBL] [Abstract][Full Text] [Related]
8. Pre- and Postnatal Diagnosis of 10p14 Deletion and 22q11.2 Deletion Syndrome and Significance of Non-Cardiac Markers.
Shetty M; Srikanth A; Kadandale J; Hegde S
Cytogenet Genome Res; 2016; 148(4):249-55. PubMed ID: 27300488
[TBL] [Abstract][Full Text] [Related]
9. A case of congenitally absent left internal carotid artery: vascular malformations in 22q11.2 deletion syndrome.
Johnson MD; Gentry LR; Rice GM; Mount DL
Cleft Palate Craniofac J; 2010 May; 47(3):314-7. PubMed ID: 19860531
[TBL] [Abstract][Full Text] [Related]
10. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis.
Prasad S; Katina S; Hennessy RJ; Murphy KC; Bowman AW; Waddington JL
Am J Med Genet A; 2015 Mar; 167A(3):529-36. PubMed ID: 25691406
[TBL] [Abstract][Full Text] [Related]
11. Association of airway abnormalities with 22q11.2 deletion syndrome.
Sacca R; Zur KB; Crowley TB; Zackai EH; Valverde KD; McDonald-McGinn DM
Int J Pediatr Otorhinolaryngol; 2017 May; 96():11-14. PubMed ID: 28390597
[TBL] [Abstract][Full Text] [Related]
12. 22q11.2DS deletion syndrome: developmental milestones in infants and toddlers.
Roizen NJ; Antshel KM; Fremont W; AbdulSabur N; Higgins AM; Shprintzen RJ; Kates WR
J Dev Behav Pediatr; 2007 Apr; 28(2):119-24. PubMed ID: 17435462
[TBL] [Abstract][Full Text] [Related]
13. Thyroid gland and carotid artery anomalies in 22q11.2 deletion syndromes.
de Almeida JR; James AL; Papsin BC; Weksburg R; Clark H; Blaser S
Laryngoscope; 2009 Aug; 119(8):1495-500. PubMed ID: 19507237
[TBL] [Abstract][Full Text] [Related]
14. 22q11.2 deletion detected by endoscopic observation of pharyngeal pulsations in a child with submucous cleft palate and persistent velopharyngeal insufficiency.
Ysunza A; Chaiyasate K; Micale MA; McBrien MM; Bloom DA; Gibson DP; Weinhouse E
Int J Pediatr Otorhinolaryngol; 2014 Oct; 78(10):1789-94. PubMed ID: 25108874
[TBL] [Abstract][Full Text] [Related]
15. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.
Taylor MD; Gokgoz N; Andrulis IL; Mainprize TG; Drake JM; Rutka JT
Am J Hum Genet; 2000 Apr; 66(4):1403-6. PubMed ID: 10739763
[TBL] [Abstract][Full Text] [Related]
16. 22q11.2 deletion syndrome lowers seizure threshold in adult patients without epilepsy.
Wither RG; Borlot F; MacDonald A; Butcher NJ; Chow EWC; Bassett AS; Andrade DM
Epilepsia; 2017 Jun; 58(6):1095-1101. PubMed ID: 28448680
[TBL] [Abstract][Full Text] [Related]
17. Perioperative risk factors in patients with 22q11.2 deletion syndrome requiring surgery for velopharyngeal dysfunction.
Stransky C; Basta M; McDonald-McGinn DM; Solot CB; Drummond D; Zackai E; LaRossa D; Kirschner R; Jackson O
Cleft Palate Craniofac J; 2015 Mar; 52(2):183-91. PubMed ID: 24805875
[TBL] [Abstract][Full Text] [Related]
18. [22q11.2 microdeletion syndrome: Analysis of the care pathway before the genetic diagnosis].
Ingrao T; Lambert L; Valduga M; Bosser G; Albuisson E; Leheup B
Arch Pediatr; 2017 Nov; 24(11):1067-1075. PubMed ID: 28967605
[TBL] [Abstract][Full Text] [Related]
19. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
20. Neuroradiographic findings in 22q11.2 deletion syndrome.
Bohm LA; Zhou TC; Mingo TJ; Dugan SL; Patterson RJ; Sidman JD; Roby BB
Am J Med Genet A; 2017 Aug; 173(8):2158-2165. PubMed ID: 28577347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
